As of 10:30 AM on the 14th, Jinwon Life Sciences is trading at 32,550 KRW, up 1.09% from the previous day. This is a 23.23% decrease compared to September 22. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 8,000 shares. Over the past five days, individual investors have net sold 23,481 shares, while foreigners and institutions have net sold 5,216 shares and 1,111 shares, respectively.


On October 7, Jinwon Life Sciences became an issue in the market with the announcement of a paper on the mechanism of action of a COVID-19 preventive nasal spray, stating a 6.8%...





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing